WHAT IS IT ALL ABOUT?

The Global Liver Health Forum objective is to enhance knowledge on the identification and intervention strategies employed in the management of MAFLD/MASLD and the identification of the associated metabolic risks, it gathers experts across the globe to bring the latest perspectives on this important topic.

  • MAFLD in Focus: Unveiling Insights from China's RELIEF Study
    Insights from APASL 2024
  • Metabolic and Toxic Liver Damage in focus
    MANPOWER's Latest Breakthroughs Revealed
  • Shedding Light on Genomic, Metabolic, and Phenotypic Effects of Essential Phospholipids on HepaRG
  • Metabolic Comorbidities Unmasked
    Redefining MASLD/MASH Impact

OUR EXPERTS

WHAT WAS IT ALL ABOUT

DO NOT LOOSE THE CHANCE!

Welcome and Introduction

Dr A. Dajani

 

MAFLD in Focus: Unveiling Insights from China's RELIEF Study - Insights from APASL 2024

Professor Wei Lai

 

Metabolic and Toxic Liver Damage in focus - MANPOWER’s Latest Breakthroughs Revealed

Dr A. Dajani

 

Shedding Light on Genomic, Metabolic, and Phenotypic Effects of Essential Phospholipids on HepaRG

Professor P. Luciani

 

Metabolic Comorbidities Unmasked - Redefining MASLD/MASH Impact

Professor Hartleb

 

Q&A

 

Summary and closing remarks

Dr A. Dajani

FIND OUT MORE ABOUT THE PREVIOUS GLOBAL LIVER HEALTH FORUMS AT WWW.GLOBALLIVERFORUM.COM/EN OR SCAN THE QR CODE

Global Liver Forum link adress QR code

DISCOVER MORE